Insulet Clarifies FDA Injury Reports on Device Correction

Insulet ( (PODD) ) just unveiled an update.

On March 12, 2026, Insulet disclosed a voluntary medical device correction after receiving 18 reports of Serious Adverse Events linked to its product. On April 10, 2026, the company updated customers, adding 13 expired lots to the affected products and confirming 29 Serious Adverse Events, while stating the financial impact estimate remained unchanged.

On April 29, 2026, the U.S. Food and Drug Administration reported that Insulet had submitted 476 serious injury reports associated with the issue as of April 17, but the company clarified these were Medical Device Reports potentially related to the correction, distinct from the 29 confirmed Serious Adverse Events. The clarification aims to prevent confusion among regulators, investors, and patients about the scale and severity of incidents tied to the device correction.

The most recent analyst rating on (PODD) stock is a Hold with a $220.00 price target. To see the full list of analyst forecasts on Insulet stock, see the PODD Stock Forecast page.

Spark’s Take on PODD Stock

According to Spark, TipRanks’ AI Analyst, PODD is a Neutral.

The score is driven primarily by strong financial performance (high margins, improved cash generation, and a much less levered 2025 balance sheet) and a constructive earnings outlook with continued growth, margin expansion, and buybacks. These positives are tempered by weak technicals (price below key moving averages with negative MACD) and a premium valuation (P/E ~81) that leaves less room for execution missteps amid guidance deceleration and higher capex/interest headwinds.

To see Spark’s full report on PODD stock, click here.

More about Insulet

Insulet Corporation is a medical device company that develops and markets insulin delivery systems for people with diabetes. Its products focus on wearable insulin pump technologies, positioning the company within the diabetes care and broader healthcare technology markets.

Average Trading Volume: 993,790

Technical Sentiment Signal: Sell

Current Market Cap: $13.04B

For a thorough assessment of PODD stock, go to TipRanks’ Stock Analysis page.